Prosecution Insights
Last updated: April 19, 2026

Prevail Therapeutics Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18273845 MODULATION OF AAV-BASED GENE EXPRESSION PRONZATI, GINA 1633 Non-Final OA Jul 24, 2023
18031494 ASSAY FOR MEASURING POTENCY OF GENE THERAPY DRUG PRODUCT PARKIN, JEFFREY S 1671 Non-Final OA Apr 12, 2023
18041199 GENE THERAPIES FOR NEURODEGENERATIVE DISORDERS LARA, CAROLINE MONSERRAT 1633 Non-Final OA Feb 09, 2023
18019357 AAV VECTORS ENCODING PARKIN AND USES THEREOF HUMPHRIES, NICHOLAS ADAM 1631 Non-Final OA Feb 02, 2023

Managing Prevail Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month